Skip to main content

Table 10 Stem cell

From: Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network

 

2021

2018

2013

% change (%)

Bone marrow

 US

794

585

189

320.1

 INT’L

2539

1953

839

202.6

 Global

3333

2538

1028

224.2

Peripheral stem cells

 US

227

131

53

328.3

 INT’L

1111

729

401

177.1

 Global

1338

860

454

194.7

Cord blood

 US

151

147

47

221.3

 INT’L

515

408

144

257.6

 Global

666

555

191

248.7

Total, including “other”

 US

1284

865

290

342.8

 INT’L

4180

3097

1392

200.3

 Global

5464

3962

1682

224.9

  1. The number of patients reported to receive transplantation through the source of bone marrow, peripheral stem cells, cord blood, or other stem cell sources in 2021, 2018, and 2013